Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 6, 2025
Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example
Daniel Weintraub, Michael C Brumm, Ryan Kurth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 29, 2025
Reply to: "Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example"
Daniel Weintraub, Michael C Brumm, Ryan Kurth, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Utilizing Intraindividual Cognitive Variability to Predict Early Neuronal Synuclein Disease Progression
Hannah L Combs, Ryan Kurth, Anuprita Nair, et al.
NPJ Parkinson'S Disease
|
October 1, 2025
Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and older
Kerri A Pierz, Whitley Aamodt, Caroline Gochanour, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Neurology
|
May 14, 2026
Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
Ethan G Brown, Lana M Chahine, Roseanne D Dobkin, et al.
Annals of Neurology
|
December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease
Ethan G Brown, Lana M Chahine, Andrew Siderowf, et al.
Annals of Clinical and Translational Neurology
|
April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy
Daniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
The Lancet. Neurology
|
April 14, 2023
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 6, 2025
Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example
Daniel Weintraub, Michael C Brumm, Ryan Kurth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 29, 2025
Reply to: "Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example"
Daniel Weintraub, Michael C Brumm, Ryan Kurth, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Utilizing Intraindividual Cognitive Variability to Predict Early Neuronal Synuclein Disease Progression
Hannah L Combs, Ryan Kurth, Anuprita Nair, et al.
NPJ Parkinson'S Disease
|
October 1, 2025
Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and older
Kerri A Pierz, Whitley Aamodt, Caroline Gochanour, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Neurology
|
May 14, 2026
Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
Ethan G Brown, Lana M Chahine, Roseanne D Dobkin, et al.
Annals of Neurology
|
December 25, 2024
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease
Ethan G Brown, Lana M Chahine, Andrew Siderowf, et al.
Annals of Clinical and Translational Neurology
|
April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy
Daniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
The Lancet. Neurology
|
April 14, 2023
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, et al.
Page
of 2